CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05%

Product NDC
72934-1050
11-digit product format
729341050
Labeler code
72934
Product ID
72934-1050_8878edb5-6d17-5633-e053-2995a90a1486
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05%
Dosage form
GEL
Route
TOPICAL
Labeler
Sincerus Florida, LLC
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2019-05-10
Marketing end
0000-00-00
Substance
TAZAROTENE; NIACINAMIDE; CLINDAMYCIN PHOSPHATE
Active strength
0 g/100g; g/100g; g/100g
Pharmacologic classes
Retinoid [EPC],Retinoids [CS],Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS]
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a107c35c-2cb4-4734-a92b-e9ed5cfc34d6Product name220260220
a46239a7-5963-4008-8cbb-6b9000f497ebProduct name120250721
1426d8f8-b7d5-4053-8554-613df00c0d86Product name220250616
b382b4e1-6b48-45f6-bffc-e61b00b0ce19Product name320250317
5993ea1b-833d-fa4b-caad-a0d477537538Product name520250305
d8f81258-db12-0761-46cc-8ff6e62e9302Product name420240422
b7b2fa42-1c77-d724-81f0-87da60a77e79Product name320240320
c24b0f4e-b27e-8e2b-a129-1b5a6d72c459Product name220231128
b27c7c65-51f2-a62f-e0e6-a26b3a0f8eb0Product name320230425
e3af9708-3004-7392-4046-5311eaa8bab5Product name320221128
ffb4bacf-f636-0f7d-0b0d-7a4b151243e3Product name920220928
b72227d6-0388-43bd-995b-b762d2754cd5Product name120220706
a92d22e0-3af4-f301-bc88-27ff030b0070Product name220220316
4a7d44fe-774d-404b-aad0-8a90fe78375aProduct name420211025
18da2240-e326-4d63-90cd-d6bb15f662a0Product name120200604
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27bProduct name320200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992Product name420190619
5ce6ce33-4f2b-3ce0-757d-e520013280cfProduct name520180719
b92a26f1-6926-4817-be73-e26ab4c2146fProduct name120170602
028d6c95-5012-6976-2075-dee0ae6fefe2Product name120140508
468b2c08-8adb-8d0f-8257-c6515a061424Product name120140508
8959fb29-d86f-c521-666a-b4cb22233594Product name120140508
a32b252c-8cd2-cc4a-c64c-4b9d3916df9eProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72934-1050-22021-01-29C16284748780-1ba0f9c33-4461-a910-e053-dadaa90a0b85CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72934-1050-2CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05%30 g in 1 BOTTLE, PUMPGEL301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72934-1050CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05% GEL [SINCERUS FLORIDA, LLC]1Legacy NDC, 1 package rows20190510_8878edb5-6d16-5633-e053-2995a90a1486.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
72934-1050-27293410500230 g in 1 BOTTLE, PUMP30 gHistorical